top of page
Browse by category
Search


Despite lowering BMI threshold for eligibility, access to surgery remains low
Despite patient eligibility for bariatric surgery expanding over the last decade and its safety and effectiveness even further established in clinical studies and professional guidelines, relatively few patients with a body mass index (BMI) below 35 actually get the surgery in any given year, according to two new studies presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting. In the first study, ‘Bariatric Surgery for Low


SASI bypass safe but concerns over potential of malnutrition and excessive weight loss
Single anastomosis sleeve ileal (SASI) bypass appears to be an effective procedure for the treatment of morbid obesity and its related...


Potential role of bariatric in reducing future colorectal cancer
Bariatric surgery has the potential role in reducing future colorectal cancer (CRC) in patients with obesity at a population level,...


1.3 billion people will have diabetes by 2050
More than half a billion people are living with diabetes worldwide, affecting men, women and children of all ages in every country, and...


Sleeve gastrectomy reduced vertebral bone strength and density of adolescents
Sleeve gastrectomy has been found to have harmful effects on bones of adolescents and young adults by reduced vertebral bone strength and...


Weight recurrence after sleeve gastrectomy negatively impacts pregnancy
Weight recurrence after sleeve gastrectomy (SG) negatively impacts pregnancy and increases the probability of several complications for...


Examine weaknesses in the other mesenteric gaps for IH to reduce the risk of recurrence
Researcher from Lund University and Skåne University Hospital, Malmö, Sweden, have report that surgery for internal herniation (IH)...


Tirzepatide has unique ability to stimulate insulin secretion
Tirzepatide (Mounjaro) has a unique ability to activate two different mechanisms the body uses to control insulin secretion and energy...


AOMs help patients manage postsurgical weight recurrence
Anti-obesity medications, including semaglutide (Ozempic and Wegovy), can effectively help patients manage weight regained after...


FDA warns against using compounded semaglutide
The FDA has received adverse event reports after patients used compounded semaglutide for type 2 diabetes and weight loss. Drug...
Browse by tag






bottom of page

